Partner news
News
Partner news
Adicet Bio, Inc. Announces Pricing of $135 Million Public Offering of Common Stock and Concurrent Private Placement
Read full storyJNJ Press releases
Gathering Innovation Strength to Capture New Value Johnson & Johnson is Recognized as the First Foreign-Funded Open Innovation Platform by the Shanghai Municipal Government
Read full storyPartner news
Exonate announces the initiation of Phase Ib/II clinical trial for Diabetic Macular Oedema, as part of its collaboration with Janssen
Read full storyOther news
ViaCyte Appoints Michael Yang President and CEO and Provides Company Update
Read full storyOther news
Paige Announces Series C Funding Round of $100 Million to Accelerate Transformation of Digital Pathology
Read full storyPartner news
£10 million research collaboration to detect lung cancer earlier
Read full storyOther news
4 Ways Johnson & Johnson Advanced Much-Needed Healthcare Innovations Amid the Pandemic
Read full storyOther news
Aro Biotherapeutics Announces $88 Million Series A Financing to Advance Development of Centyrin-Targeted Genetic Medicines
Read full storyPartner news
Revitope Oncology Announces Strategic Collaboration with Janssen to Leverage its Unique T Cell Engager Platform
Read full storyPartner news
Morphic Expands Research and Development Collaboration with Janssen Through Third Integrin Program
Read full storyOther news
ONL Therapeutics Closes $46.9 Million in Series B Financing to Advance ONL1204 into Three Retinal Disease Indications
Read full storyPartner news
MacroGenics Enters Research Collaboration with Janssen to Develop Novel DART® Molecule
Read full storyOther news
XWPharma Names Michael M. Morrissey, PhD to Board of Directors
Read full storyPartner news